⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for egfr exon 20 insertion

Every month we try and update this database with for egfr exon 20 insertion cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
EMB-01 in Combination With Osimertinib in Patients With EGFR Mutant Lung CancerNCT05498389
Metastatic Lung...
Advanced Lung N...
Stage IV Lung C...
Stage IVA Lung ...
Stage IVB Lung ...
Stage III Lung ...
Stage IIIA Lung...
Stage IIIB Lung...
EGFR Mutation-R...
EMB-01
Osimertinib
18 Years - Shanghai EpimAb Biotherapeutics Co., Ltd.
Pembrolizumab Plus Bevacizumab and Chemotherapy for Non-Squamous NSCLC PatientsNCT05751187
Non-squamous NS...
Pembrolizumab
Bevacizumab
Pemetrexed
Cisplatin
Carboplatin
Folic acid 350-...
Vitamin B12 100...
Dexamethasone 4...
18 Years - 75 YearsShanghai Chest Hospital
Pembrolizumab Plus Bevacizumab and Chemotherapy for Non-Squamous NSCLC PatientsNCT05751187
Non-squamous NS...
Pembrolizumab
Bevacizumab
Pemetrexed
Cisplatin
Carboplatin
Folic acid 350-...
Vitamin B12 100...
Dexamethasone 4...
18 Years - 75 YearsShanghai Chest Hospital
A Phase I Clinical Study of HS-20117 in Participants With Advanced Solid TumorsNCT05940116
Non-Small Cell ...
Solid Tumor
HS-20117
18 Years - 75 YearsHansoh BioMedical R&D Company
Pembrolizumab Plus Bevacizumab and Chemotherapy for Non-Squamous NSCLC PatientsNCT05751187
Non-squamous NS...
Pembrolizumab
Bevacizumab
Pemetrexed
Cisplatin
Carboplatin
Folic acid 350-...
Vitamin B12 100...
Dexamethasone 4...
18 Years - 75 YearsShanghai Chest Hospital
EMB-01 in Combination With Osimertinib in Patients With EGFR Mutant Lung CancerNCT05498389
Metastatic Lung...
Advanced Lung N...
Stage IV Lung C...
Stage IVA Lung ...
Stage IVB Lung ...
Stage III Lung ...
Stage IIIA Lung...
Stage IIIB Lung...
EGFR Mutation-R...
EMB-01
Osimertinib
18 Years - Shanghai EpimAb Biotherapeutics Co., Ltd.
A Phase I Clinical Study of HS-20117 in Participants With Advanced Solid TumorsNCT05940116
Non-Small Cell ...
Solid Tumor
HS-20117
18 Years - 75 YearsHansoh BioMedical R&D Company
Phase 2 Platform Study in Patients With Advanced Non-Small Lung Cancer Who Progressed on First-Line Osimertinib Therapy (ORCHARD)NCT03944772
Non-Small Cell ...
Osimertinib
Savolitinib
Gefitinib
Necitumumab
Durvalumab
Carboplatin
Pemetrexed
Alectinib
Selpercatinib
Selumetinib
Etoposide
Cisplatin
Datopotamab der...
18 Years - 130 YearsAstraZeneca
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: